The Genetics of Familial Polyposis

Size: px
Start display at page:

Download "The Genetics of Familial Polyposis"

Transcription

1 The Genetics of Familial Polyposis Thursday, September 24 th 2015 Kara Semotiuk, MS, (C)CGC & Laura Winter, MSc, CGC Genetic Counsellors at the FGICR

2 Familial Polyposis Familial Can run in the family related to our genes Polyposis Multiple polyps Polyp: non-cancerous growth, inside the GI system Different types of polyps Adenoma: Risk to become cancer if not removed TODAY: FAP & MAP

3 FAP: Familial Adenomatous Polyposis Classic FAP: 100s-1000s of colorectal adenomas, onset as early as childhood/adolescence Can also be polyps in small bowel (duodenum) &/or stomach Somewhat higher risk for other cancers including thyroid Non-cancerous features: desmoids, CHRPE, osteomas, skin cysts, extra teeth Attenuated FAP (AFAP): less severe, fewer polyps (< 100), later onset Both FAP and AFAP are rare seen in only 3 per 100,000 people Both are caused by changes in the same gene called APC

4 Genetics Cell Genetic testing is usually done on DNA collected from a blood sample DNA Many genes Genes written in code Mutation: change in the code APC gene ONE Mutation affected Autosomal dominant inheritance Affects males & females in equal numbers Location of mutation in gene associated with classic FAP vs. AFAP Two copies of each gene One copy inherited from mom, one from dad

5 FAP: Dominant Inheritance Parent with FAP Mutation in 1 APC gene What age to test? When screening starts: FAP: yr AFAP: yr 50% (1 in 2) chance for each child to inherit FAP/AFAP

6 Inherited vs. de novo Affected parent Unaffected parents 75-80% of time FAP is inherited from a parent 20-25% of time FAP starts new in a child

7 If a child inherits a mutation in APC They have FAP / AFAP Screening for colorectal polyps Classic FAP: age AFAP: age Surgery if too many polyps to manage by colonoscopy Screening of remaining colon/rectum/pouch Upper GI screening from ~age 25 Annual thyroid palpation by GP

8 If a child did not inherit APC mutation - They do not have FAP/AFAP - They cannot pass it down to children - Population cancer screening (unless other family history) Importance of informing relatives about genetic testing: FAP screening vs. general population screening Parents, siblings, children, others

9 MUTYH-Associated Polyposis (MAP) MAP vs. (A)FAP Clinical presentation is similar: Multiple adenomatous polyps In MAP, other types of polyps such as hyperplastic or serrated polyps that can be seen in addition to adenomas polyps by age 50 on average 100 s to 1000 s of polyps in some cases Gene is different: MUTYH (MYH) Inheritance is different: Autosomal RECESSIVE inheritance

10 Recessive Inheritance If both parents are carriers (unaffected), each child has a 25% (1 in 4) chance of having MAP Brothers and sisters of someone with MAP have a 25% (1 in 4) chance of also having MAP

11 For Someone With MAP Very small chance for children to have MAP Only possible if spouse/partner is a carrier (or has MAP) - very unlikely Who should get tested in the family: Spouse/partner If negative, children don t need testing Children, if spouse/partner not available Brothers & sisters

12 MAP Screening 2 mutations (MAP) Colonoscopy every 2-3 years beginning at Every year once polyps detected Side-viewing upper endoscopy every 5 years or more often depending on findings, beginning at 25-30

13 Population Screening Or No mutation or 1 mutation (carrier): BOTH UNAFFECTED Not at significantly increased risk for polyps/cancer Follow population cancer screening unless other family history of polyps or cancer

14 Summary FAP and MAP both cause multiple polyps, BUT: Different genes (APC vs. MUTYH) Different inheritance (Dominant vs. Recessive) Different screening recommendations Genetic testing has improved over the years You may be eligible for further testing if: Your genetic testing was many years ago or your never had genetic testing You have multiple polyps and had genetic testing where nothing was found

15 Genetic Questions? *** Speak to your genetic counsellor *** Dr. Zane Cohen (centre), with genetic counsellors (L to R) Melyssa Aronson, Spring Holter, Kara Semotiuk & Laura Winter

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP)

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP) A Patient s Guide to risk assessment Adenomatous Polyposis Syndromes (FAP/AFAP and MAP) Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary cancer

More information

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP)

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP) A Patient s Guide to risk assessment Adenomatous Polyposis Syndromes (FAP/AFAP and MAP) Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary cancer

More information

GENETIC MANAGEMENT OF A FAMILY HISTORY OF FAP or MUTYH ASSOCIATED POLYPOSIS. Family Health Clinical Genetics. Clinical Genetics department

GENETIC MANAGEMENT OF A FAMILY HISTORY OF FAP or MUTYH ASSOCIATED POLYPOSIS. Family Health Clinical Genetics. Clinical Genetics department GENETIC MANAGEMENT OF A FAMILY HISTORY OF FAP or MUTYH ASSOCIATED POLYPOSIS Full Title of Guideline: Author (include email and role): Division & Speciality: GUIDELINES FOR THE GENETIC MANAGEMENT OF A FAMILY

More information

Pathology reports, related operative reports and consult letters must be provided with a request for assessment.

Pathology reports, related operative reports and consult letters must be provided with a request for assessment. Page 1 of 6 Polyposis Syndromes Inherited risk for colorectal cancer is associated with a number of polyposis syndromes (genes), some of which are well-defined and others are less common. Identification

More information

Understanding and Managing Lynch Syndrome

Understanding and Managing Lynch Syndrome Understanding and Managing Lynch Syndrome Princess Margaret For women who may have Lynch syndrome and their family members Please visit the UHN Patient Education website for more health information: www.uhnpatienteducation.ca

More information

For identification, support and follow up related to Familial Gastrointestinal Cancer conditions. South Island Cancer Nurses Network September 2013

For identification, support and follow up related to Familial Gastrointestinal Cancer conditions. South Island Cancer Nurses Network September 2013 For identification, support and follow up related to Familial Gastrointestinal Cancer conditions South Island Cancer Nurses Network September 2013 Who are we? Specialist multidisciplinary team: Nurse coordinators,

More information

Update from the 2011 symposium: MOH testing criteria

Update from the 2011 symposium: MOH testing criteria Update from the 2011 symposium: MOH testing criteria Melyssa Aronson, MS, (C)CGC Zane Cohen Centre for Digestive Disease May 26, 2017 Criteria Working Group 2011 Symposium Concerns expressed: Last revised

More information

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious Understanding Your Genetic Test Result Positive for a Deleterious Mutation or Suspected Deleterious This workbook is designed to help you understand the results of your genetic test and is best reviewed

More information

Familial and Hereditary Colon Cancer

Familial and Hereditary Colon Cancer Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of

More information

Classification of polyposis syndromes two major groups. Adenomatous polyposis syndromes. Hamartomatous polyposis syndromes

Classification of polyposis syndromes two major groups. Adenomatous polyposis syndromes. Hamartomatous polyposis syndromes Hereditary polyposis syndromes Classification of polyposis syndromes two major groups adenomatous and non-adenomatous polyposis syndromes Adenomatous polyposis syndromes Familial adenomatous polyposis(fap)

More information

An Introduction to MUTYH Associated Polyposis (MAP)

An Introduction to MUTYH Associated Polyposis (MAP) An Introduction to MUTYH Associated Polyposis (MAP) 1 An Introduction to MUTYH Associated Polyposis(MAP) Contents What is MUTYH Associated Polyposis (MAP)? 2 What causes MUTYH Associated Polyposis (MAP)?

More information

Cancer Genomics 101. BCCCP 2015 Annual Meeting

Cancer Genomics 101. BCCCP 2015 Annual Meeting Cancer Genomics 101 BCCCP 2015 Annual Meeting Objectives Identify red flags in a person s personal and family medical history that indicate a potential inherited susceptibility to cancer Develop a systematic

More information

A Patient s Guide to risk assessment. Hereditary Colorectal Cancer

A Patient s Guide to risk assessment. Hereditary Colorectal Cancer A Patient s Guide to risk assessment Hereditary Colorectal Cancer Hereditary Cancer Testing: Is it Right for You? Overview of Syndromes This workbook is designed to help you decide if hereditary cancer

More information

Familial Adenomatous Polyposis

Familial Adenomatous Polyposis Familial Adenomatous Polyposis 1 in 10,000 incidence 100 s to 1000 s of colonic adenomas by teens Cancer risk: colon, gastric, duodenum (periampulla), small bowel, pancreas, papillary thyroid, childhood

More information

Hereditary Colorectal Cancer

Hereditary Colorectal Cancer A Patient s Guide to risk assessment Hereditary Colorectal Cancer Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary cancer testing is right for

More information

Risk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE

Risk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE Identifying the Patient at Risk for an Inherited Syndrome Sapna Syngal, MD, MPH, FACG Director, Gastroenterology Director, Familial GI Program Dana-Farber/Brigham and Women s Cancer Center Associate Professor

More information

BowelGene. How do I know if I am at risk? Families with hereditary bowel cancer generally show one or more of the following clues:

BowelGene. How do I know if I am at risk? Families with hereditary bowel cancer generally show one or more of the following clues: BowelGene BowelGene What is hereditary bowel cancer? Bowel cancer (also known as colorectal cancer) is the fourth most common cancer in the UK. Unfortunately 1 in 19 women and 1 in 14 men will develop

More information

Familial and Hereditary Colon Cancer

Familial and Hereditary Colon Cancer Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of

More information

GHUK BowelGene_2017.qxp_Layout 1 22/02/ :22 Page 3 BowelGene

GHUK BowelGene_2017.qxp_Layout 1 22/02/ :22 Page 3 BowelGene GHUK BowelGene_2017.qxp_Layout 1 22/02/2017 10:22 Page 3 BowelGene BowelGene What is hereditary bowel cancer? Bowel cancer (also known as colorectal cancer) is the fourth most common cancer in the UK.

More information

Understanding Your Genetic Test Result. Positive for Two Copies of an MYH Mutation

Understanding Your Genetic Test Result. Positive for Two Copies of an MYH Mutation Understanding Your Genetic Test Result Positive for Two Copies of an MYH Mutation This workbook is designed to help you understand the results of your genetic test and is best reviewed with your healthcare

More information

FAMILIAL COLORECTAL CANCER. Lyn Schofield Manager Familial Cancer Registry

FAMILIAL COLORECTAL CANCER. Lyn Schofield Manager Familial Cancer Registry FAMILIAL COLORECTAL CANCER Lyn Schofield Manager Familial Cancer Registry Cancer in WA 2004 4000 3500 ASPR, rate per 100,000 3000 2500 2000 1500 1000 Male incidence Female incidence Male mortality Female

More information

COLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University

COLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University COLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University 1. I am a surgeon; of course I have nothing to disclose.

More information

What All of Us Should Know About Cancer and Genetics

What All of Us Should Know About Cancer and Genetics What All of Us Should Know About Cancer and Genetics Beth A. Pletcher, MD, FAAP, FACMG Associate Professor of Pediatrics UMDNJ- New Jersey Medical School Disclosures I have no relevant financial relationships

More information

An Introduction to Serrated Polyposis Syndrome (SPS)

An Introduction to Serrated Polyposis Syndrome (SPS) An Introduction to Serrated Polyposis Syndrome (SPS) An Introduction to Serrated Polyposis Syndrome (SPS) 3 An Introduction to Serrated Polyposis Syndrome (SPS) Contents What is Serrated Polyposis Syndrome

More information

12: BOWEL CANCER IN FAMILIES

12: BOWEL CANCER IN FAMILIES 12: BOWEL CANCER IN FAMILIES 12.1 INTRODUCTION TO GENETICS AND INHERITANCE The human body is made up of billions of cells (such as skin cells, brain cells, nerve cells, etc). Almost every cell in the body

More information

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP) Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP) A Patient s Guide to risk assessment Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary

More information

FACT SHEET 49. What is meant by a family history of bowel cancer? What is bowel cancer? What causes bowel cancer?

FACT SHEET 49. What is meant by a family history of bowel cancer? What is bowel cancer? What causes bowel cancer? Important points The most important factors that can influence an individual s chance of developing bowel cancer are getting older and having a family history of bowel cancer A family history of bowel

More information

Hereditary GI tumor syndromes ACG guidelines of genetic testing and management. Dr. med. Henrik Csaba Horváth PhD

Hereditary GI tumor syndromes ACG guidelines of genetic testing and management. Dr. med. Henrik Csaba Horváth PhD Hereditary GI tumor syndromes ACG guidelines of genetic testing and management Dr. med. Henrik Csaba Horváth PhD Genetic testing and management of hereditary GI tumor syndromes June 29, 2016 2 Clinical

More information

Hereditary Colorectal Cancer Syndromes Miguel A. Rodriguez-Bigas, MD

Hereditary Colorectal Cancer Syndromes Miguel A. Rodriguez-Bigas, MD Hereditary Colorectal Cancer Syndromes Miguel A. Rodriguez-Bigas, MD Living Beyond Cancer A-Z January 12,2019 Hereditary CRC Syndromes Objectives are to discuss the : Most common Hereditary CRC syndromes

More information

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP) Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP) A Patient s Guide to risk assessment Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary

More information

Disclosure. Agenda. I do not have any relevant financial/non financial relationships with any proprietary interests

Disclosure. Agenda. I do not have any relevant financial/non financial relationships with any proprietary interests Luis Rohena, MD Chief, Medical Genetics San Antonio Military Medical Center Assistant Professor of Pediatrics USUHS & UTHSCSA 15JUNE2014 51st Annual Teaching Conference Pediatrics for the Practitioner

More information

Disclosure. Polyps in Pediatrics. Learning Objectives. Case Presentation I. Case Presentation II

Disclosure. Polyps in Pediatrics. Learning Objectives. Case Presentation I. Case Presentation II Disclosure Polyps in Pediatrics I have no relationships with commercial companies to disclose. Sonal Desai, MD Division of Pediatric Gastroenterology May 31, 2013 Pediatric Grand Rounds Learning Objectives

More information

Policy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014

Policy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014 Medical Policy Genetic Testing for Colorectal Cancer Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Laboratory/Pathology Original Policy Date: Effective Date: October

More information

ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes

ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes Sapna Syngal, MD, MPH, FACG, 1,2,3 Randall E. Brand, MD, FACG, 4 James M. Church, MD, FACG, 5,6,7

More information

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014 COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014 WENDY MCKINNON, MS, CGC CERTIFIED GENETIC COUNSELOR FAMILIAL CANCER PROGRAM UNIVERSIT Y OF VERMONT MEDICAL CENTER 1 CHARACTERISTICS

More information

Caring for Patients at Risk for Hereditary Colorectal Cancer

Caring for Patients at Risk for Hereditary Colorectal Cancer February 05, 2007 By Karen Greco, PhD, RN, ANP [1] About 6% of colorectal cancers are caused by genetic mutations associated with hereditary colorectal cancer syndromes. The most common hereditary cancer

More information

Colorectal Cancer and Hereditary Colon Cancer Syndromes Carol A. Burke, M.D.

Colorectal Cancer and Hereditary Colon Cancer Syndromes Carol A. Burke, M.D. Colorectal Cancer and Hereditary, FACG, FACP Sanford R. Weiss MD Center for Hereditary Colorectal Neoplasia Digestive Disease Institute Cleveland Clinic, Cleveland, Ohio 1 Objectives Review the molecular

More information

CLINICAL FOCUS. Juvenile Polyposis. Winter 2009

CLINICAL FOCUS. Juvenile Polyposis. Winter 2009 CLINICAL FOCUS Juvenile Polyposis Carol Durno, MD, MSc Registry Pediatric Gastroenterologist People can have many polyps in the gastrointestinal tract. The type and number of polyps found help determine

More information

Genetic Testing for Familial Gastrointestinal Cancer Syndromes. C. Richard Boland, MD La Jolla, CA January 21, 2017

Genetic Testing for Familial Gastrointestinal Cancer Syndromes. C. Richard Boland, MD La Jolla, CA January 21, 2017 Genetic Testing for Familial Gastrointestinal Cancer Syndromes C. Richard Boland, MD La Jolla, CA January 21, 2017 Disclosure Information C. Richard Boland, MD I have no financial relationships to disclose.

More information

Colorectal Cancer Syndromes. Barbara Jung, MD AGAF Associate Professor and Chief University of Illinois at Chicago

Colorectal Cancer Syndromes. Barbara Jung, MD AGAF Associate Professor and Chief University of Illinois at Chicago Colorectal Cancer Syndromes Barbara Jung, MD AGAF Associate Professor and Chief University of Illinois at Chicago Outline Colon cancer General Genetics, Risk, Screening Specific Syndromes, when to suspect,

More information

BUY ONE GENE, GET ONE 30 FREE! G E N E P A N E L T E S T I N G F O R H E R E D I T A R Y C A N C E R : G E T T I N G I T R I G H T THIS COULD BE YOU ONE DAY SOON: Starting out in your new OB/Gyn practice

More information

Information leaflet for families with a history of bowel cancer or polyps. MYH Polyposis

Information leaflet for families with a history of bowel cancer or polyps. MYH Polyposis Information leaflet for families with a history of bowel cancer or polyps MYH Polyposis What is MYH? MYH is an inherited condition which causes people to be predisposed to developing bowel polyps and cancers.

More information

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Policy Number: Original Effective Date: MM.02.007 09/01/2011 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration

More information

colorectal cancer Colorectal cancer hereditary sporadic Familial 1/12/2018

colorectal cancer Colorectal cancer hereditary sporadic Familial 1/12/2018 colorectal cancer Adenocarcinoma of the colon and rectum is the third most common site of new cancer cases and deaths in men (following prostate and lung or bronchus cancer) and women (following breast

More information

Colonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern

Colonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern Colonic polyps and colon cancer Andrew Macpherson Director of Gastroentology University of Bern Improtance of the problem of colon cancers - Epidemiology Lifetime risk 5% Incidence/10 5 /annum (US Detroit

More information

Primary Care Approach to Genetic Cancer Syndromes

Primary Care Approach to Genetic Cancer Syndromes Primary Care Approach to Genetic Cancer Syndromes Jason M. Goldman, MD, FACP FAU School of Medicine Syndromes Hereditary Breast and Ovarian Cancer (HBOC) Hereditary Nonpolyposis Colorectal Cancer (HNPCC)

More information

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian ANNOUNCER OPEN: Welcome to CME on ReachMD. This segment, entitled Inherited Susceptibility to Cancer: What Do Primary Care Providers

More information

HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007

HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 MIT OpenCourseWare http://ocw.mit.edu HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms.

More information

PENETRANCE ACTIONABILITY SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS. YES ( 1 of above) YES (Proceed to Stage II)

PENETRANCE ACTIONABILITY SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS. YES ( 1 of above) YES (Proceed to Stage II) Stage I: Binning Dashboard GENE/GENE PANEL: APC ACTIONABILITY 1. Is there a qualifying resource, such as a practice guideline or systematic review, for the genetic condition? 2. Does the practice guideline

More information

Colon Cancer Screening and Surveillance. Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011

Colon Cancer Screening and Surveillance. Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011 Colon Cancer Screening and Surveillance Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011 Colorectal Cancer Preventable cancer Number 2 cancer killer in the USA Often curable if detected

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: familial_adenomatous_polyposis_and_mutyh_associated_polyposis 1/1/2019 NA 1/1/2020 1/1/2019 Description of

More information

B Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696

B Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696 Index Note: Page numbers of article titles are in boldface type. A Adenomatous polyposis, familial. See Familial adenomatous polyposis. Anal anastomosis, ileal-pouch, proctocolectomy with, in FAP, 591

More information

GI EMERGENCIES Acute Abdominal Pain

GI EMERGENCIES Acute Abdominal Pain GI EMERGENCIES Acute Abdominal Pain Marcia Cruz-Correa, MD, PhD, AGAF. FASGE Associate Professor of Medicine, Biochemistry, Surgery Director Translational Research University of Puerto Rico Comprehensive

More information

Objectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background

Objectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background Colorectal Cancer Screening Payam Afshar, MS, MD Kaiser Permanente, San Diego Objectives Colorectal cancer background Colorectal cancer screening populations Colorectal cancer screening modalities Colonoscopy

More information

Colorectal Neoplasia. Dr. Smita Devani MBChB, MRCP. Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi

Colorectal Neoplasia. Dr. Smita Devani MBChB, MRCP. Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi Colorectal Neoplasia Dr. Smita Devani MBChB, MRCP Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi Case History BT, 69yr male Caucasian History of rectal bleeding No change

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_colon_cancer 5/2004 8/2017 8/2018 8/2017 Description of Procedure or Service Genetic

More information

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious Understanding Your Genetic Test Result Positive for a Deleterious Mutation or Suspected Deleterious This workbook is designed to help you understand the results of your genetic test and is best reviewed

More information

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Policy Number: 2.04.08 Last Review: 1/2018 Origination: 1/2004 Next Review: 1/2019 Policy Blue Cross and Blue Shield of Kansas

More information

Frameshift Mutations (Deletion at Codon 1309 and Codon 849) in the APC Gene in Iranian FAP Patients: a Case Series and Review of the Literature

Frameshift Mutations (Deletion at Codon 1309 and Codon 849) in the APC Gene in Iranian FAP Patients: a Case Series and Review of the Literature IJMCM Summer 2014, Vol 3, No 3 Case Series Frameshift Mutations (Deletion at Codon 1309 and Codon 849) in the APC Gene in Iranian FAP Patients: a Case Series and Review of the Literature Seyed Mohammad

More information

FAMILIAL ADENOMATOUS POLYPOSIS (COLORECTAL CANCER) PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES

FAMILIAL ADENOMATOUS POLYPOSIS (COLORECTAL CANCER) PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES FAMILIAL ADENOMATOUS POLYPOSIS (COLORECTAL CANCER) PREFERRED MODEL OF CARE AND CRITERIA FOR REFERENCE CENTRES Coordinator: Alex Kartheuser (Colorectal Surgery, Cliniques universitaires St-Luc, UCL) Authors

More information

Duodenal adenomas Management. Dr Stratis Alexandridis Consultant Gastroenterologist BRI

Duodenal adenomas Management. Dr Stratis Alexandridis Consultant Gastroenterologist BRI Duodenal adenomas Management Dr Stratis Alexandridis Consultant Gastroenterologist BRI Introduction Ampullary and non ampullary polyps of the duodenum are diagnosed within and outside genetic syndromes.

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Genetic Testing for Lynch Syndrome and Other Inherited Page 1 of 34 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Genetic Testing for Lynch Syndrome and Other

More information

Hereditary Gastric Cancer

Hereditary Gastric Cancer Hereditary Gastric Cancer Dr Bastiaan de Boer Consultant Pathologist Department of Anatomical Pathology PathWest Laboratory Medicine, QE II Medical Centre Clinical Associate Professor School of Pathology

More information

ACG Clinical Guideline: Colorectal Cancer Screening

ACG Clinical Guideline: Colorectal Cancer Screening ACG Clinical Guideline: Colorectal Cancer Screening Douglas K. Rex, MD, FACG 1, David A. Johnson, MD, FACG 2, Joseph C. Anderson, MD 3, Phillip S. Schoenfeld, MD, MSEd, MSc (Epi), FACG 4, Carol A. Burke,

More information

Result Navigator. Positive Test Result: BMPR1A. After a positive test result, there can be many questions about what to do next. Navigate Your Results

Result Navigator. Positive Test Result: BMPR1A. After a positive test result, there can be many questions about what to do next. Navigate Your Results Result Navigator Positive Test Result: BMPR1A Positive test results identify a change, or misspelling, of DNA that is known or predicted to cause an increased risk for cancer. DNA is the blueprint of life

More information

GI Polyp syndromes in children. Screening and surveillance, surgery.

GI Polyp syndromes in children. Screening and surveillance, surgery. Dr Warren Hyer Consultant Paediatric Gastroenterologist St Mark s Hospital, UK GI Polyp syndromes in children Screening and surveillance, surgery. No conflict of interests to declare Objectives Understand

More information

TumorNext-Lynch. genetic testing for hereditary colorectal or uterine cancer

TumorNext-Lynch. genetic testing for hereditary colorectal or uterine cancer TumorNet-Lynch genetic testing for hereditary colorectal or uterine cancer What Are the Causes of Hereditary Colorectal Cancer? sporadic 70% familial 20% hereditary 10% Lynch syndrome, up to 4% Familial

More information

Colorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital

Colorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital Colorectal Cancer - Working in Partnership David Baty Genetics, Ninewells Hospital Genetics and Pathology National initiatives Colorectal cancer Inherited CRC Sporadic CRC The Liquid Biopsy The future?

More information

Genetic Testing for Lynch Syndrome and Inherited Intestinal Polyposis Syndromes

Genetic Testing for Lynch Syndrome and Inherited Intestinal Polyposis Syndromes Genetic Testing for Lynch Syndrome and Inherited Intestinal Polyposis Syndromes Policy Number: 2.04.08 Last Review: 1/2014 Origination: 1/2004 Next Review: 1/2015 Policy Blue Cross and Blue Shield of Kansas

More information

Hereditary Non Polyposis Colorectal Cancer(HNPCC) From clinic to genetics

Hereditary Non Polyposis Colorectal Cancer(HNPCC) From clinic to genetics From clinic to genetics Question 1) Clinical pattern of inheritance of the HNPCC-Syndrome? Question 1) Clinical pattern of inheritance of the HNPCC-Syndrome? Autosomal dominant Question 2) Incidence of

More information

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana,

More information

OPEN ACCESS TEXTBOOK OF GENERAL SURGERY

OPEN ACCESS TEXTBOOK OF GENERAL SURGERY OPEN ACCESS TEXTBOOK OF GENERAL SURGERY COLORECTAL POLYPS P Goldberg POLYP A polyp is a localised elevated lesion arising from a epithelial surface. If it has a stalk it is called a pedunculated polyp

More information

CLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING

CLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING CLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING This guideline is designed to assist practitioners by providing the framework for colorectal cancer (CRC) screening, and is not intended to replace

More information

Hemochromatosis - Genetic Inheritance

Hemochromatosis - Genetic Inheritance Hemochromatosis - Genetic Inheritance Inheritance Combinations for HFE Hemochromatosis (Autosomal Recessive Inheritance) If both parents are carriers of one C282Y mutation for the HFE-hemochromatosis gene,

More information

PATIENT BROCHURE. 441 Charmany Dr 1 Madison WI, RX Only

PATIENT BROCHURE. 441 Charmany Dr 1 Madison WI, RX Only PATIENT BROCHURE 441 Charmany Dr 1 Madison WI, 53719 844-870- 8870 Cologuard colorectal cancer screening test is a registered trademark of Exact Sciences Corporation. Indications for Use Cologuard is intended

More information

Joint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies. Ashish Sangal, M.D.

Joint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies. Ashish Sangal, M.D. Joint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies Ashish Sangal, M.D. Cancer Screening: Consensus & Controversies Ashish Sangal, MD Director,

More information

Genetic Testing for Lynch Syndrome And Other Inherited Colon Cancer Syndromes

Genetic Testing for Lynch Syndrome And Other Inherited Colon Cancer Syndromes Genetic Testing for Lynch Syndrome And Other Inherited Colon Cancer Syndromes Policy Number: Original Effective Date: MM.02.007 09/01/2011 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration

More information

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana,

More information

Timing of surgery in FAP

Timing of surgery in FAP Timing of surgery in FAP Sue Clark Consultant Colorectal Surgeon, The Polyposis Registry, St Mark s Hospital, London, UK. 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60 60-65 65-70

More information

David P. Ryan, M.D. Clinical Director, MGH Cancer Center Chief, Hematology-Oncology, MGH

David P. Ryan, M.D. Clinical Director, MGH Cancer Center Chief, Hematology-Oncology, MGH Colon Cancer 2015 David P. Ryan, M.D. Clinical Director, MGH Cancer Center Chief, Hematology-Oncology, MGH Colon Cancer Case presentation 72yo woman presented 1/03 abd discomfort and nausea Found to have

More information

During the past decade the genetic etiology of all of. Genetic Testing for Inherited Colon Cancer

During the past decade the genetic etiology of all of. Genetic Testing for Inherited Colon Cancer GASTROENTEROLOGY 2005;128:1696 1716 Genetic Testing for Inherited Colon Cancer RANDALL BURT*, and DEBORAH W. NEKLASON*, *Huntsman Cancer Institute, Salt Lake City; and Departments of Medicine and Oncological

More information

What a history of cancer may mean for you and your family and the steps you can take to reduce the risk

What a history of cancer may mean for you and your family and the steps you can take to reduce the risk What a history of cancer may mean for you and your family and the steps you can take to reduce the risk www.myriadtests.com 1-800-469-7423 Family Ties and Colon Cancer In every family, certain traits are

More information

Family history of pancreatic cancer

Family history of pancreatic cancer Family history of pancreatic cancer _ This fact sheet is for people who want to find out about the hereditary risk of pancreatic cancer. You can speak to our specialist nurses on our Support Line about

More information

Hereditary Cancer Update: What do GPOs need to know?

Hereditary Cancer Update: What do GPOs need to know? Hereditary Cancer Update: What do GPOs need to know? Mary McCullum, RN, MSN, CON(C) Nurse Educator, Hereditary Cancer Program BC Cancer Agency October 1, 2016 Conflict of Interest Disclosure Nothing to

More information

Update on Hereditary Gastric Cancer. Dr. Savtaj Brar MD MSc Surgical Oncologist Assistant Professor of Surgery

Update on Hereditary Gastric Cancer. Dr. Savtaj Brar MD MSc Surgical Oncologist Assistant Professor of Surgery Update on Hereditary Gastric Cancer Dr. Savtaj Brar MD MSc Surgical Oncologist Assistant Professor of Surgery Disclosures None Outline 1. Discuss new consensus guidelines on hereditary diffuse gastric

More information

Information for You and Your Family

Information for You and Your Family Information for You and Your Family What is Prevention? Cancer prevention is action taken to lower the chance of getting cancer. In 2017, more than 1.6 million people will be diagnosed with cancer in the

More information

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Section 2.0 Medicine Subsection 2.04 Pathology/Laboratory

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Section 2.0 Medicine Subsection 2.04 Pathology/Laboratory 2.04.08 Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Section 2.0 Medicine Subsection 2.04 Pathology/Laboratory Effective Date January 30, 2015 Original Policy Date October

More information

Mr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer

Mr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer Mr Chris Wakeman General Surgeon University of Otago, Christchurch 12:15-12:40 Management of Colorectal Cancer Bowel cancer Chris Wakeman Colorectal Surgeon Christchurch Sam Simon (Simpsons) Elizabeth

More information

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Genetic Testing for Inherited Susceptibility to Colon Cancer Page 1 of 24 Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Title: Genetic Testing for Inherited Susceptibility

More information

Endoscopic techniques for surveillance and treatment of FAP

Endoscopic techniques for surveillance and treatment of FAP Endoscopic techniques for surveillance and treatment of FAP Evelien Dekker MD PhD Department of Gastroenterology & Hepatology Academic Medical Center Amsterdam The Netherlands FAP: endoscopic surveillance

More information

The Role of the Surgical Pathologist in the Diagnosis of Rare Polyposis Syndromes 1. Lynch Syndrome

The Role of the Surgical Pathologist in the Diagnosis of Rare Polyposis Syndromes 1. Lynch Syndrome The Role of the Surgical Pathologist in the Diagnosis of Rare Polyposis Syndromes Dr Christophe Rosty. Envoi Pathology and University of Queensland, Brisbane, QLD, Australia. Email: c.rosty@uq.edu.au Presented

More information

FAMILIAL ADENOMATOUS POLYPOSIS SBS11QHG-06 DANIEL KANTER PERIOD 6 #9

FAMILIAL ADENOMATOUS POLYPOSIS SBS11QHG-06 DANIEL KANTER PERIOD 6 #9 FAMILIAL ADENOMATOUS POLYPOSIS SBS11QHG-06 DANIEL KANTER PERIOD 6 #9 PHYSIOLOGY The colon plays one of the most important roles in the body, extracting salt and water from the wastes and eventually creating

More information

Colorectal Cancer in 2006: New Developments

Colorectal Cancer in 2006: New Developments James J. Stark, MD Colorectal Cancer in 2006: New Developments Melissa Bennett, MS, CGC Myriad Genetic Laboratories Thomas Duntemann,, MD Ray Ramirez, Jr., MD Hereditary Colon Cancer and Genetic Testing

More information

MEDICAL POLICY SUBJECT: GENETIC TESTING FOR INHERITED SUSCEPTIBILITY TO COLORECTAL CANCER. POLICY NUMBER: CATEGORY: Laboratory Test

MEDICAL POLICY SUBJECT: GENETIC TESTING FOR INHERITED SUSCEPTIBILITY TO COLORECTAL CANCER. POLICY NUMBER: CATEGORY: Laboratory Test MEDICAL POLICY SUBJECT: GENETIC TESTING FOR INHERITED SUSCEPTIBILITY TO COLORECTAL CANCER POLICY NUMBER: 2.02.11 CATEGORY: Laboratory Test EFFECTIVE DATE: 09/16/99 REVISED DATE: 04/19/01, 05/16/02, 06/19/03,

More information

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes

Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Policy Number: 2.04.08 Last Review: 1/2019 Origination: 1/2004 Next Review: 1/2020 Policy Blue Cross and Blue Shield of Kansas

More information

Hereditary Cancer Products

Hereditary Cancer Products Hereditary Products Integrated BRACAnalysis (BRCA1 and BRCA2 sequencing and large rearrangement testing (BART)), covered when: PERSONAL HISTORY of Breast (must meet at least 1) Diagnosed

More information

Wellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 4: Colorectal Cancer Overview

Wellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 4: Colorectal Cancer Overview Wellness Along the Cancer Journey: Cancer Types Revised October 2015 Chapter 4: Colorectal Cancer Overview Cancer Types Rev. 10.20.15 Page 35 Colorectal Cancer Overview Group Discussion True False Not

More information

So, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes.

So, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes. Hello. My name is Maureen Mork and I m a Certified Genetic Counselor in the Clinical Cancer Genetics Program at The University of Texas MD Anderson Cancer Center. I ll be lecturing today on the Cancer

More information

Bowel Cancer Prevention and Screening. Harriet Wynne, Cancer Council Victoria

Bowel Cancer Prevention and Screening. Harriet Wynne, Cancer Council Victoria Bowel Cancer Prevention and Screening Harriet Wynne, Cancer Council Victoria New cases and deaths for the Victoria population in 2013 Thursfield V, et al. Cancer in Victoria: Statistics & trends 2013.

More information